Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation - PubMed (original) (raw)
Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation
Cheng-Jun Hu et al. Mol Cell Biol. 2003 Dec.
Abstract
Transcriptional responses to hypoxia are primarily mediated by hypoxia-inducible factor (HIF), a heterodimer of HIF-alpha and the aryl hydrocarbon receptor nuclear translocator subunits. The HIF-1alpha and HIF-2alpha subunits are structurally similar in their DNA binding and dimerization domains but differ in their transactivation domains, implying they may have unique target genes. Previous studies using Hif-1alpha(-/-) embryonic stem and mouse embryonic fibroblast cells show that loss of HIF-1alpha eliminates all oxygen-regulated transcriptional responses analyzed, suggesting that HIF-2alpha is dispensable for hypoxic gene regulation. In contrast, HIF-2alpha has been shown to regulate some hypoxia-inducible genes in transient transfection assays and during embryonic development in the lung and other tissues. To address this discrepancy, and to identify specific HIF-2alpha target genes, we used DNA microarray analysis to evaluate hypoxic gene induction in cells expressing HIF-2alpha but not HIF-1alpha. In addition, we engineered HEK293 cells to express stabilized forms of HIF-1alpha or HIF-2alpha via a tetracycline-regulated promoter. In this first comparative study of HIF-1alpha and HIF-2alpha target genes, we demonstrate that HIF-2alpha does regulate a variety of broadly expressed hypoxia-inducible genes, suggesting that its function is not restricted, as initially thought, to endothelial cell-specific gene expression. Importantly, HIF-1alpha (and not HIF-2alpha) stimulates glycolytic gene expression in both types of cells, clearly showing for the first time that HIF-1alpha and HIF-2alpha have unique targets.
Figures
FIG. 1.
786-O cells express HIF-2α but not HIF-1α. 786-O (PRC-3) is a _VHL_-defective renal carcinoma cell line, whereas 786-O (WT-8) cells have been stably transfected with functional VHL (38). RCC-4 is another _VHL_-mutant renal carcinoma cell line, expressing both HIF-1α and HIF-2α. The RCC-4 (T3-14) cells have been stably transfected with functional VHL. Enhanced expression of HIF-1α mRNA in _VHL_-transfected RCC-4 cells has previously been observed (55). Hypoxia (H) treatment (1.5% O2 for 16 h) stabilized HIF-2α protein in 786-O (WT-8) cells and stabilized both HIF-1α and HIF-2α in RCC-4 (T3-14) cells as shown by HIF-1α and HIF-2α Western blots. The ARNT Western blot served as a protein loading control.
FIG. 2.
Confirmation of DNA microarray data by Northern blot analyses. (A) Hypoxia (H) (1.5% O2 for 16 h) stimulates expression of ADRP, NDRG-1, ADM, and VEGF in both 786-O (WT-8) and RCC-4 (T3-14) cells and is likely to be HIF-dependent since these genes are overexpressed in the parental 786-O (PRC-3) and RCC-4 cells independent of O2. Severe hypoxia (SH) (0.1% O2 for 16 h) further enhances hypoxic gene expression in comparison to 1.5% O2. (B) GADD45A and CHOP are hypoxia-responsive genes but are independent of HIF activity. (C) PGK-1, LDHA, PGM-1, and PKM mRNAs, which encode four glycolytic enzymes, are not stimulated by hypoxic treatment (1.5 or 0.1% O2) of 786-O cells but are induced in RCC-4 cells.
FIG. 3.
HIF-1α is associated with hypoxic induction of glycolytic genes in multiple cell types. (A) Northern blot analysis of HIF-1α and HIF-2α expression in two primary endothelial cell lines and three transformed cell lines. HIF-1α is expressed in all five lines with similar levels, whereas HIF-2α is expressed highly in two endothelial cells. (B) Western blot analysis of HIF-1α and HIF-2α protein in cells treated with hypoxia-mimetic DFX (100 μM) for 6 h. The levels of HIF-1α and HIF-2α protein expression are in general agreement with their mRNA levels, except for the levels of HIF-1α in HMVEC-L cells and HIF-2α in Hep3B cells. (C) Hypoxic treatment (1.5% O2 for 16 h) increases the expression of the glycolytic genes (PGK and LDHA) and HIF-2α inducible genes (NDRG-1 and VEGF) in all five cell lines.
FIG. 4.
HIF-1α expression in 786-O cells restores the glycolytic gene response to hypoxia treatment. (A) Establishment and characterization of 786-O (WT-8) clones stably transfected with HIF-1α. WT-8L cells express low levels of HIF-1α, whereas WT-8H cells express higher levels of HIF-1α as demonstrated by HIF-1α Northern blot and Western blot assays. The pcDNA3 vector-transfected control WT-8V cells and parental WT-8 cells express no HIF-1α RNA or protein. HEK293 cells, whose endogenous HIF-1α mRNA (asterisk) exhibits a larger size than transfected HIF-1α mRNA (double asterisk), served as positive control for HIF-1α protein. (B) Northern blot analysis of two glycolytic genes in HIF-1α-rescued WT-8 cells, showing that LDHA and PGK-1 are induced in WT-8H cells after treatment with 1.5% O2 for 16 h. The level of induction in WT-8H is comparable to that in HEK293 cells by endogenous HIF-1α.
FIG. 5.
Mutagenesis of hydroxylated prolines confers HIF-1α and HIF-2α function to normoxic cells. (A) Schematic representation of HIF-1α and HIF-2α single and double proline mutants. (B) Double proline HIF-1α and HIF-2α mutants are stabilized under normal O2 tension. HEK293-T cells transfected with wild-type single-proline mutant and double-proline mutant HIF-α subunits were split into two dishes, one of which was treated with DFX for 6 h before nuclear extraction preparation. The amount of HIF-α protein was measured by Western blot analysis with specific antibodies and a nonspecific (NS) band is shown for protein loading control. (C) HIF-α double proline mutants are highly active in wild-type (WT)-HRE-Luc reporter transactivation assays in normoxic cells. The mutant (MT)-HRE-Luc reporters are not regulated by HIF-1α or HIF-2α.
FIG. 6.
Establishment of HEK293 TET-on HIF-1αDPA and HIF-2αDPA clones. (A) HIF-α mRNA expression is tightly regulated by doxycycline. Northern blot analysis of HIF-1α and HIF-2α mRNA expression in HEK293 TET-on HIF-1αDPA clone 130 (left) and HEK293 TET-on HIF-2αDPA clone 63 (right) treated with different amounts of doxycycline for 20 h. (B) Doxycycline (1 μg/ml for 20 h) induced HIF-1α mRNA and protein expression in two independent HEK293 TET-on HIF-1αDPA clones (left) and HIF-2α mRNA and protein expression in two independent HEK293 TET-on HIF-2αDPA clones (right). Dox. conc., concentration of doxycycline.
FIG. 7.
HIF-1α and not HIF-2α stimulates genes encoding glycolytic enzymes in HEK293 TET-on cells. (A) Northern blot analysis of two glycolytic genes and two HIF-2α-responsive genes in HEK293 TET-on HIF-1αDPA clones treated with 1 μg of doxycycline/ml for 20 h (+). −, no doxycycline. HIF-1α increases the transcription of all four genes. (B) Northern blot analysis of two glycolytic genes and two HIF-2α-responsive genes in HEK293 TET-on HIF-2αDPA clones treated with 1 μg of doxycycline/ml for 20 h. HIF-2α induced NDRG-1 and VEGF expression but not glycolytic gene expression. (C) Addition of doxycycline (1 μg/ml) increases the glucose usage of a HEK293 TET-on HIF-1DPA clone but not a HEK293 TET-on HIF-2DPA clone or HEK293 TET-on parental cells. The percent change of glucose usage was defined as [glucose (−Dox) − glucose (+DOX)]/glucose (−DOX). (D) Doxycycline treatment (1 μg/ml for 48 h) increases VEGF protein secretion in both HEK293 TET-on HIF-1DPA and HIF-2DPA clones.
Similar articles
- Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells.
Hu CJ, Iyer S, Sataur A, Covello KL, Chodosh LA, Simon MC. Hu CJ, et al. Mol Cell Biol. 2006 May;26(9):3514-26. doi: 10.1128/MCB.26.9.3514-3526.2006. Mol Cell Biol. 2006. PMID: 16611993 Free PMC article. - Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha.
Uchida T, Rossignol F, Matthay MA, Mounier R, Couette S, Clottes E, Clerici C. Uchida T, et al. J Biol Chem. 2004 Apr 9;279(15):14871-8. doi: 10.1074/jbc.M400461200. Epub 2004 Jan 26. J Biol Chem. 2004. PMID: 14744852 - Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells.
Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, Wiesener M, Eckardt KU. Warnecke C, et al. FASEB J. 2004 Sep;18(12):1462-4. doi: 10.1096/fj.04-1640fje. Epub 2004 Jul 1. FASEB J. 2004. PMID: 15240563 - The HIF pathway: implications for patterns of gene expression in cancer.
Wykoff CC, Pugh CW, Harris AL, Maxwell PH, Ratcliffe PJ. Wykoff CC, et al. Novartis Found Symp. 2001;240:212-25; discussion 225-31. doi: 10.1002/0470868716.ch15. Novartis Found Symp. 2001. PMID: 11727931 Review. - The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses.
Bracken CP, Whitelaw ML, Peet DJ. Bracken CP, et al. Cell Mol Life Sci. 2003 Jul;60(7):1376-93. doi: 10.1007/s00018-003-2370-y. Cell Mol Life Sci. 2003. PMID: 12943226 Free PMC article. Review.
Cited by
- Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery-An Updated Review on Their Multifaceted Therapeutic Applications (2020-2024).
Mo X, Rao DP, Kaur K, Hassan R, Abdel-Samea AS, Farhan SM, Bräse S, Hashem H. Mo X, et al. Molecules. 2024 Oct 9;29(19):4770. doi: 10.3390/molecules29194770. Molecules. 2024. PMID: 39407697 Free PMC article. Review. - Hypoxia-mediated rescue of retinal ganglion cells deficient in mitochondrial complex I is independent of the hypoxia-inducible factor pathway.
Warwick AM, Bomze HM, Wang L, Hao Y, Stinnett SS, Gospe SM 3rd. Warwick AM, et al. Sci Rep. 2024 Oct 15;14(1):24114. doi: 10.1038/s41598-024-75916-x. Sci Rep. 2024. PMID: 39406814 Free PMC article. - Hypoxic reactivation of Kaposi's sarcoma associated herpesvirus.
Singh RK, Torne AS, Robertson ES. Singh RK, et al. Cell Insight. 2024 Sep 7;3(6):100200. doi: 10.1016/j.cellin.2024.100200. eCollection 2024 Dec. Cell Insight. 2024. PMID: 39391006 Free PMC article. Review. - HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis.
Czopik AK, McNamee EN, Vaughn V, Huang X, Bang IH, Clark T, Wang Y, Ruan W, Nguyen T, Masterson JC, Tak E, Frank S, Collins CB, Li H, Rodriguez-Aguayo C, Lopez-Berestein G, Gerich ME, Furuta GT, Yuan X, Sood AK, de Zoeten EF, Eltzschig HK. Czopik AK, et al. Nat Commun. 2024 Sep 14;15(1):8042. doi: 10.1038/s41467-024-52113-y. Nat Commun. 2024. PMID: 39271652 Free PMC article. - Targeting Hypoxia and HIF1α in Triple-Negative Breast Cancer: New Insights from Gene Expression Profiling and Implications for Therapy.
Han D, Li Z, Luo L, Jiang H. Han D, et al. Biology (Basel). 2024 Jul 31;13(8):577. doi: 10.3390/biology13080577. Biology (Basel). 2024. PMID: 39194515 Free PMC article.
References
- Alvarez-Tejado, M., S. Naranjo-Suarez, C. Jimenez, A. C. Carrera, M. O. Landazuri, and L. del Peso. 2001. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J. Biol. Chem. 276:22368-22374. - PubMed
- Arsham, A. M., D. R. Plas, C. B. Thompson, and M. C. Simon. 2002. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem. 277:15162-15170. - PubMed
- Bandyopadhyay, R. S., M. Phelan, and D. V. Faller. 1995. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim. Biophys. Acta 1264:72-78. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources